Media About Us


  • 16 September 2016

    No More Reading Glasses? New Implant May Help With Aging Eyes

    No More Reading Glasses? New Implant May Help With Aging Eyes

    NBC NEWS

    The Raindrop implant reshapes the cornea to correct nearsightedness. Cheri Eckstadt, of Minnesota, is about to become the first person in the nation to get the newly-approved FDA device.

  • 16 September 2016

    So long, reading glasses? New Raindrop eye implant could make them obsolete

    So long, reading glasses? New Raindrop eye implant could make them obsolete

    Today

    Thanks to a new eye implant called the Raindrop, a five-minute procedure could make reading glasses a thing of the past. NBC News medical contributor Dr. John Torres reports on the first patient to undergo the procedure since it received FDA approval.

  • 12 September 2016

    Pfizer goes local with Russian joint venture - Doing Business With Russia

    Pfizer goes local with Russian joint venture - Doing Business With Russia

    Kira Egorova / Doing Business With Russia

    The American pharmaceutical corporation is building a new facility south of Moscow to capitalize on support from government initiatives, which is also indicative of its commitment to the local market. 

  • 07 September 2016

    Pfizer goes local with Russian joint venture

    Pfizer goes local with Russian joint venture

    Kira Egorova / Russia Beyond the Headlines

    In July 2016, the U.S. pharmaceutical giant Pfizer became the first foreign company in its sector to localize its business in Russia with a Russian partner. Pfizer and the Russian-American company NovaMedica, whose shareholders include the Russian state-owned company Rusnano, decided to jointly invest in the construction of a plant in the Kaluga Region, 125 miles southwest of Moscow.

  • 01 September 2016

    FDA-Approved Raindrop Near Vision Inlay Corrects Blurry Reading Vision -- Now Available in Utah for the First Time

    FDA-Approved Raindrop Near Vision Inlay Corrects Blurry Reading Vision -- Now Available in Utah for the First Time

    Yahoo Finance

    Most people begin to notice a decline in their near vision in their early 40s and 50s, which typically occurs as a result of a frustrating but inevitable age-related change in vision called presbyopia. Fortunately, recent advancements in technology provide surgical options to improve near vision and offer patients restored visual independence. On June 29, 2016, The U.S. Food and Drug Administration (FDA) approved the Raindrop® Near Vision Inlay -- a surgical implant produced by ReVision Optics, Inc. -- used to help improve near vision in patients between the ages of 45-65 years old who suffer from presbyopia.

  • 23 August 2016

    Jeffrey Whitman, M.D., Will Be the First Dallas Eye Doctor to Implant Commercial Raindrop® Near Vision Inlays in U.S.

    Jeffrey Whitman, M.D., Will Be the First Dallas Eye Doctor to Implant Commercial Raindrop® Near Vision Inlays in U.S.

    PRWEB

    Following extensive clinical trials, the Food and Drug Administration (FDA) approved the Raindrop Near Vision Inlay, a tiny, clear, implantable medical device, to improve near vision in some patients with presbyopia. FDA approval was granted June 29, 2016.

  • 11 August 2016

    Follow the Money: US Companies Shrug Off Politics and Invest in Russia

    Follow the Money: US Companies Shrug Off Politics and Invest in Russia

    Sputnik

    In spite of the US government's best efforts to sanction the Russian economy, many US companies are continuing or even increasing their investment in Russia, wrote Forbes columnist Kenneth Rapoza.

  • 01 August 2016

    Will Liquid Biopsies Transform Oncology Clinical Trials?

    Will Liquid Biopsies Transform Oncology Clinical Trials?

    Ed Miseta / Clinical Leader

    Epic Sciences says it has developed a technology that CEO Murali Prahalad believes will transform oncology trials by identifying and characterizing circulating tumor cells. Those cells have been long recognized as a key part of cancer metastasis. Tumors shed these cells into the circulatory system where they then travel to different parts of the body and, under the right conditions, become the genesis of new tumors.

  • 20 July 2016

    Pfizer Partners with NovaMedica to Build Manufacturing Unit in Russia

    Jerry Boling / Market Digest

    Pfizer Inc. (NYSE: PFE) is currently in the process of developing several manufacturing units in a number of geographical territories all over the world. Just recently, the pharmaceutical giant inked its third major deal in the in the past couple of years. This huge deal involves a partnership with NovaMedica of Russia to establish a manufacturing facility in the country.

  • 19 July 2016

    Pfizer agrees to license 30 products to Russian pharma company

    Pfizer agrees to license 30 products to Russian pharma company

    Life Sciences IP Review

    US drugs company Pfizer has entered into a manufacturing and licensing agreement with Russian pharmaceutical company NovaMedica. Pfizer has proposed to invest in NovaMedica’s construction of a new manufacturing plant in the Kaluga region.